Peptide-Based Cancer Immunotherapy

Bispecific Peptides in Cancer: Immune Cell Bridges

Bispecific peptides connect T cells to tumors by binding two targets at once. From tebentafusp to neoantigen vaccines, the evidence and the limitations.